Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Trading Down 2.6 %

Shares of NYSE:MLSS opened at $0.86 on Wednesday. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.10. The company has a market capitalization of $66.42 million, a PE ratio of -8.60 and a beta of 1.08. The business has a 50 day moving average of $0.97 and a two-hundred day moving average of $0.80.

Milestone Scientific (NYSE:MLSS) last announced its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Milestone Scientific had a negative net margin of 54.87% and a negative return on equity of 60.78%. The company had revenue of $1.85 million during the quarter.

Insider Transactions at Milestone Scientific

In related news, Director Leonard Osser sold 141,913 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total value of $134,817.35. Following the completion of the transaction, the director now directly owns 4,602,506 shares of the company’s stock, valued at approximately $4,372,380.70. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold a total of 143,122 shares of company stock valued at $136,026 in the last three months. 24.75% of the stock is currently owned by company insiders.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.